* Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed ToddSimpson vice president of finance and administration and chieffinancial officer.
* Arqule Inc., of Medford, Mass., appointed Eric Gordon presidentand CEO and John Sorvillo vice president of business developmentand named as chairman, Joseph Hogan, Arqule's chief scientificfounder.
* Biogen Inc., of Cambridge, Mass., made the followingappointments: David Konys, country manager for Canada; KathrynHenry, director of compensation, benefits and human resourcesinformation systems; Wendy Jones, director of bioassay; SumanPatel, director of technical services; William Dillon, SoutheasternU.S. regional sales director; Mona Hayes, Northeastern U.S. regionalsales director; Robert Perez, Western U.S. regional sales director;and Roger Lane, Southwestern regional sales director.
* Centocor Inc., of Malvern, Pa., named Donald Perryman vicepresident of worldwide marketing and sales for the pharmaceuticaldivision.
* Corvas International Inc., of San Diego, appointed Donald Pickerexecutive vice president and chief operating officer.
* Cytel Corp., of San Diego, named Robert Roe executive vicepresident and chief operating officer.
* Idec Pharmaceuticals Corp., of San Diego, appointed PhillipSchneider vice president and chief financial officer.
* Idun Pharmaceuticals Inc., of San Diego, appointed Michael Aylottpresident and chief operating officer.
* Ilex Oncology Inc., of San Antonio, named Kathleen Heck directorof clinical services, Bill Mikrut director of biostatistics, EverettaWoods medical writer and Gayle Cooke project leader.
* ImmuLogic Pharmaceutical Corp., of Waltham, Mass., appointedBrian Bollwage vice president of regulatory affairs, Susan Primrosedirector of investor relations and corporate communications andDavid Tolley vice president of process development andmanufacturing.
* Interferon Sciences Inc., of New Brunswick, N.J., named LawrenceGordon CEO and Stanley Schutzbank president and appointed asvice chairman, Samuel Ronel, the former Interferon president andCEO.
* Neoprobe Corp., of Dublin, Ohio, made the followingappointments: Louis Cosentino, vice president of marketing andcorporate development; Dana Thomas, director of global distribution;James Carni, director of process development; Dale Slifko, projectmanager of instruments; Paul Miller, compliance associate; and LydiaChen, computer specialist.
* Pharmavene Inc., of Rockville, Md., named to its board LawrenceHoff, formerly president and chief operating officer of Upjohn Co.,of Kalamazoo, Mich.
* Quintiles Transnational Corp., of Research Triangle Park, N.C.,made the following appointments: Barry Sachais, vice president ofclinical operations for Quintiles Pacific Inc.; Amanda Rowan,director of clinical operations; and Michael Ibara, senior drug safetyscientist and head of systems.
* Receptagen Ltd., of Edmonds, Wash., named Albert Chiassonchairman and CEO.
* Sequus Pharmaceuticals Inc., of Menlo Park, Calif., named EdwardSchnipper senior vice president and medical director.
* Shaman Pharmaceuticals Inc., of South San Francisco, made thefollowing appointments: Steven King, senior vice president ofethnobotany and conservation; Gerald Reaven, senior vice presidentof research; and Atul Khandwala, senior vice president ofdevelopment.
(c) 1997 American Health Consultants. All rights reserved.